The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Open accessAbstract
This study aimed to determine if there is an association between dysbiosis and nonalcoholic fatty liver disease (NAFLD) independent of obesity and insulin resistance (IR). This is a prospective cross-sectional study assessing the intestinal microbiome (IM) of 39 adults with biopsy-proven NAFLD (15 simple steatosis [SS]; 24 nonalcoholic steatohepatitis [NASH]) and 28 healthy controls (HC). IM composition (llumina MiSeq Platform) in NAFLD patients compared to HC were identified by two statistical methods (Metastats, Wilcoxon). Selected taxa was validated using quantitative PCR (qPCR). Metabolites in feces and serum were also analyzed. In NAFLD, 8 operational taxonomic units, 6 genera, 6 families and 2 phyla (Bacteroidetes, Firmicutes) were less abundant and; 1 genus ( Lactobacillus ) and 1 family (Lactobacillaceae) were more abundant compared to HC. Lower abundance in both NASH and SS patients compared to HC were confirmed by qPCR for Ruminococcus, Faecalibacterium prausnitzii and Coprococcus . No difference was found between NASH and SS. This lower abundance in NAFLD (NASH+SS) was independent of BMI and IR. NAFLD patients had higher concentrations of fecal propionate and isobutyric acid and serum 2-hydroxybutyrate and L-lactic acid. These findings suggest a potential role for a specific IM community and functional profile in the pathogenesis of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, diseases linked to dyslipidemia, such as non-alcoholic liver disease and atherosclerosis, are associated with changes in gut microbiota profile.”
From Dietary lipids, gut microbiota and lipid metabolism (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 21,098
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Research works printed but not linked: 1
- Doelle, H. W. Bacterial Metabolism. Second edn, 416–419 (Academic Press, Inc., 1975).
Cited by
Sorted by citations
Items 201–283 of 283
Anavi, S., Tsybina-Shimshilashvili, N., Zandani, G., Hovav, R. H., Sela, N., Nyska, A., & Madar, Z. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1205377 · Cited by 9
Birg, A., Lin, H. C., & Kanagy, N. L. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06597-5 · Cited by 7
Green, N., Chan, C., & Ooi, C. Y. (2024) · Pediatric Pulmonology · doi:10.1002/ppul.26913 · Cited by 6
Fecal calprotectin in patients with liver cirrhosis
Jothimani, D. K., Paramasivam, R., Manoharan, M., Ramachandran, H., Muthusamy, S., Simon, E. B., Ravichandran, J., & Rela, M. (2023) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01450-9 · Cited by 7
Potential clinical usefulness of gut microbiome testing in a variety of clinical conditions
Morten, K., Staines-Urias, E., & Kenyon, J. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.08.003 · Cited by 6
Fermented Foods and the Gut–Liver Axis: Modulation of MASLD Through Gut Microbiota
Wesołek, A., Rosiejka, D., Bogdanska, K., & Bogdański, P. (2026) · Nutrients · doi:10.3390/nu18030542 · Cited by 5
Gut microbiota involvement in the effect of water-soluble dietary fiber on fatty liver and fibrosis
Sato, S., Iino, C., Chinda, D., Sasada, T., Go, S. O. M. A., Tateda, T., Furusawa, K., Yoshida, K., Sawada, K., Mikami, T., et al. (2024) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2024-046 · Cited by 6
da Silva, V. G., Roy, N. C., Smith, N. W., Wall, C. R., Mullaney, J. A., & McNabb, W. C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1591341 · Cited by 7
Hernández, M. A. G., Canfora, E. E., & Blaak, E. E. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0179 · Cited by 5
Falalyeyeva, T. M., Kobyliak, N. M., Korotkyi, O., Meleshko, T., Sulaieva, O., Hryshchenko, I., Domylivska, L., & Boyko, N. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-19564-8_5 · Cited by 5
Dogra, S. K., Dardinier, A., Mainardi, F., Siegwald, L., Bártová, S., Roy, C. I. L., & Chou, C. J. (2023) · Nutrients · doi:10.3390/nu15061311 · Cited by 5
Yong, Z., Shi, H., Zhou, Y.-H., Wang, A., Kang, D., & Kang, L. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2021.67.5.29 · Cited by 5
Yan, Q., Li, X., Zhou, X., Chen, W., Tian, X., Wittayakun, S., Paengkoum, P., & Tan, Z. (2024) · Animal nutrition · doi:10.1016/j.aninu.2024.04.014 · Cited by 4
Wyss, J., Raselli, T., Wyss, A., Telzerow, A., Rogler, G., Krupka, N., Yılmaz, B., Schmidt, T., & Misselwitz, B. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03195-7 · Cited by 4
Dai, Z., Bao, Z., Lin, H., Yang, Q., Huang, J., Zhang, X., Luo, N., Tang, H., & Zhou, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-88420-7 · Cited by 4
Rol de la microbiota intestinal en el desarrollo del hígado graso no alcohólico
Tumani, M. F., Tapia, G., Aguirre, C. A., Obregón, A. M., & Pettinelli, P. (2021) · Revista médica de Chile · doi:10.4067/s0034-98872021000400570 · Cited by 5
Meenatchi, R., Singh, P., Ahmed, Z. H. T., Thacharodi, A., Rohinth, M., Kumar, R. R., K, H. V. M., & Hassan, S. (2023) · doi:10.22541/au.169200028.86242834/v1 · Cited by 3
Wang, N., Wu, M.-J., Gu, W., Dai, C., Shao, Z., & Subbalakshmi, K. P. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf217 · Cited by 5
Hu, J.-C. E., Zhou, C., Zhang, L., Chen, Y., Li, J., Li, J., & Duan, L. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00752-x · Cited by 3
Wu, J., Zheng, W., Ding, X., Jin, Q., & Ding, M. (2025) · Future Science OA · doi:10.1080/20565623.2025.2599729 · Cited by 3
Mousavi, S. M., Ardakani, M. R., Galehdari, H., & Dorostghoal, M. (2026) · iScience · doi:10.1016/j.isci.2026.114721 · Cited by 3
Pinanga, Y. D., Pyo, K., Shin, E., Lee, H., Lee, E. H., Kim, W., Kim, S., Kim, J. E., Kim, S., & Lee, S. E. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123164 · Cited by 3
de Sandy-Galán, D. A. D., Villamil‐Ramírez, H., Rodríguez‐Cruz, M., López-Contreras, B. E., León‐Mimila, P., Olivares-Arévalo, M., Maldonado‐Hernández, J., Domínguez-Calderón, I., Salmerón, J., Cerqueda‐García, D., et al. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/6652392 · Cited by 4
Wang, W., Li, J., Mu, L., Bai, Y., Zhu, M., Zhao, Y., Hu, S., Wang, J., Shao, P. L., & Su, X. (2025) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr37275 · Cited by 5
Microbiome Diagnostics and Interventions in Health and Disease
Dasgupta, N., Srivastava, A., Rao, A., Murugkar, V., Shroff, R., & Das, G. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_10 · Cited by 3
Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl4-induced liver fibrosis
Ikeuchi, K., Tsutsumi, T., Ishizaka, A., Mizutani, T., Sedohara, A., Koga, M., Tamaoki, S., & Yotsuyanagi, H. (2023) · Gut Pathogens · doi:10.1186/s13099-023-00541-4 · Cited by 3
MAFLD under the lens: the role of gut microbiota
Sousa, P., & Machado, M. V. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2022.15 · Cited by 3
Demyanova, E. V., Shcherbakova, E. S., Sall, T. S., Бакулин, И. Г., Vakhitov, T., & Sitkin, S. I. (2021) · The Open Biomarkers Journal · doi:10.2174/1875318302111010017 · Cited by 3
Li, Z., Liu, Y., Wang, Y., Cai, Q., Wang, Y., Bai, Y., Liu, H., Xu, C., & Zhang, F. (2024) · Biology of Reproduction · doi:10.1093/biolre/ioae058 · Cited by 2
Hepatic Steatosis and Microbiota: A Regional Study on Patients from Western Romania
Mihele, A. I., John, H. T., Negruţ, N., Ferician, A. C., Marian, P., & Manole, F. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7010009 · Cited by 2
Nobel, Y. R., Park, H., Tillman, A. M., Seeram, D., Moallem, D. H., Intara, A., Nandakumar, R., Annavajhala, M. K., Gomez‐Simmonds, A., Verna, E. C., et al. (2025) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000928 · Cited by 2
Hazaimeh, R. A., Shackelford, L. A., & Boateng, J. A. (2026) · Nutrients · doi:10.3390/nu18020181 · Cited by 2
Leite, A. R., Dias, J., Godinho, T., Correia-Chaves, J., Borges‐Canha, M., Lourenço, I. M., Leite-Moreira, A. F., & Neves, J. S. (2024) · Endocrinology Insights · doi:10.1159/000541442 · Cited by 3
Chen, T., Grefhorst, A., & Holleboom, A. G. (2025) · Lipidology · doi:10.3390/lipidology2020010 · Cited by 2
Microbiome: Current Status and Future Applications
Ramos-Jiménez, R. G., & Morowitz, M. J. (2019) · Success in academic surgery · doi:10.1007/978-3-030-14644-3_14 · Cited by 2
Paniz, G. R., Arroyo-Mercado, F. M. M., Ling, C. L., Choi, E. E., Snow, H. E., Rakov, N. E., & Castillo, E. F. (2021) · medRxiv · doi:10.1101/2021.05.27.21257690 · Cited by 2
Saenz, M., McDonough, J. C., Bloom‐Saldana, E., Irimia, J. M., Cauble, E. L., Castillo, A., Fueger, P. T., & Treviño, L. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.19.540989 · Cited by 2
Joshi, D., Chauhan, K., Oberoi, H. S., Kumar, D. D., & Taneja, N. K. (2026) · Discover Biotechnology · doi:10.1007/s44340-026-00053-2 · Cited by 1
Ren, J., Perhat, S. H., Gao, M., Hao, C., Malipati-Nuertai, & Li, Y. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107203 · Cited by 1
Role of diet in shaping the gut microbiome
Siddiqui, B., Tiwari, S., Fatima, S., & Abdin, M. Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00027-3
Ishikawa, R., Nakamura, M., Sakurai, A., Nakayama-Imaohji, H., Kuwahara, T., Ichimura‐Shimizu, M., Shishibori, M., & Kataoka, K. (2026) · The Journal of Medical Investigation · doi:10.2152/jmi.73.186 · Cited by 1
Recent advances and clinical relevance of microbiome dynamics in health and disease
Gavanji, S., Suhail, M., Bencúrová, E., Dandekar, T., & Othman, E. M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2679197 · Cited by 4
Clister, D., Chandra, Q. M., Tan, M.-S., Gunawan, M. C., Bibi, A., Ahmed, A., Bastian, M., Meesakul, P., Cao, S., Kim, B., et al. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101596 · Cited by 1
Andreae, M., Clark, W. A., Sterrett, J. D., Adkins, J. L., Moorman, J. P., & Cartwright, B. M. (2026) · Nutrients · doi:10.3390/nu18142328 · Cited by 1
Salazar, N., González, S., Gavilan, C. G. D. L. R., & Ríos-Covián, D. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-07389-2_4 · Cited by 1
Predicting colorectal adenomatous polyps in patients with chronic liver disease: A novel nomogram
Li, Y., Kuai, W., Chen, L., Zeng, M.-H., Tao, X., Han, J.-X., Wang, Y.-K., Xu, L., Ge, L., Liu, Y., et al. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i2.99082 · Cited by 1
The role of gut microbiota in chronic liver diseases
Brillanti, S., & Alterini, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821927-0.00003-6 · Cited by 1
NMR Metabolomics for Marker Discovery of Metabolic Syndrome
Quesada‐Vázquez, S., Hernández-Baixauli, J., Navarro‐Masip, È., & Escoté, X. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-07389-2_39 · Cited by 1
Microbial communities from lean or obese are differently shaped after apple fibres supplementationPreprint
Dell’Olio, A., Scott, W. T., Taroncher-Ferrer, S., Onofre, N. S., Soriano, J. M., & Rubert, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.16.562478 · Cited by 1
Dalby, M. J., Kiu, R., Stamouli, M., Arefaine, B., Leong, L. E. X., Hales, J., Bernsmeier, C., Singanayagam, A., Støy, S. H., Maxan, M.-E., et al. (2025) · medRxiv · doi:10.1101/2025.02.13.25322003 · Cited by 1
Influência da microbiota intestinal na Doença Hepática Gordurosa Não Alcoólica
de Almeida, I. B., Barroso, W. A., & Gonçalves, C. A. (2020) · Revista Científica Multidisciplinar Núcleo do Conhecimento · doi:10.32749/nucleodoconhecimento.com.br/saude/microbiota-intestinal
Gut Microbiome and Liver Cancer
McVey, J. C., Zhang, Q., Greten, T. F., & Ma, C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_7
The pathophysiology of gut–liver connection
Maroni, L., Fianchi, F., Miele, L., & Svegliati‐Baroni, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821927-0.00002-4
Duarte, S. M., Stefano, J., Franco, L. A., Martins, R. C., Moraes, B. D. G. C., Barbeiro, D., Oliveira, N., Neri, J., Vanni, D., Sabino, E., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-655169/v1
Buzz Lightyear Connect It!: Flight Path Activity
Msfc, R. W. (2009)
Duarte, S. M. B., Stefano, J. T., Franco, L. A. M., Martins, R. C. R., Moraes, B. D. G. D. C., Barbeiro, D. F., Oliveira, N., Neri, J. M. T. R., Vanni, D. S., Sabino, É. C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-655169/v2
Impact of gut-derived metabollites on substrate metabolism and metabolic health
Gonzalez Hernandez Manuel, A. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201027mgh
Role of gut dysbiosis in chronic liver disease leading to fibrosis
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00006-8
NMR Metabolomics for Marker Discovery of Metabolic Syndrome
Quesada‐Vázquez, S., Hernández-Baixauli, J., Navarro‐Masip, È., & Escoté, X. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81304-8_39-1
Fadieienko, G. D., Gridnyev, O., Kushnir, I. Е., Chernova, V. M., Solomentseva, Т. А., Nikiforova, Y. V., & Kurinna, O. G. (2022) · Modern Gastroenterology · doi:10.30978/mg-2022-5-17
Non-alcoholic fatty liver disease in the context of the gut microbiome
Gridnyev, O., & Дубров, К. Ю. (2019) · Modern Gastroenterology · doi:10.30978/mg-2019-5-97
Chlorogenic Acid: A Promising Natural Agent for Non-Alcoholic Fatty Liver Disease Management
Honoré, S. M. (2021) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2021.18.555980
A Tour-d’Horizon of microbiota therapeutics for metabolic disorders
Saifi, S., Swaminathan, A., Devi, P., Chattopadhyay, P., Gupta, S., Garg, A., Saxena, S., Parveen, S., & Pandey, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00006-9
Microbiome and Human Health: From Dysbiosis to Therapeutic Interventions
Dhingra, G. G., Kumar, R., Sood, U., Hira, P., Kaur, J., & Lal, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-3126-2_13
Research Progress on Alginate Oligosaccharide and Gut Microbiota in Obesity
姚, 震. (2024) · Hans Journal of Food and Nutrition Science · doi:10.12677/hjfns.2024.131018
Functional Applications of Human Microbiome Diversity Studies
Nkera-Gutabara, C. K., Hurrell, T., & Naidoo, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13320-6.00039-1
Beier, J. I., Medici, V., Spencer, S. P., Fan, W., & Torok, N. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99649-5.00006-6
Zariyah, H., & Pramono, A. (2025) · Journal of Nutrition College · doi:10.14710/jnc.v14i2.48176
Shevlyukova, T. P., Bulatova, I. A., Vladimirskiy, V. E., Смирнова, E. N., Trofimova, E. S., & Yusupova, A. A. (2025) · Perm Medical Journal · doi:10.17816/pmj42420-40
Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease: A Mini Review
Yaghmaei, H., Taromiha, A., Nojoumi, S. A., Soltanipur, M., Shahshenas, S., Rezaei, M., Mirhosseini, S. M., Hosseini, S. M., & Siadat, S. D. (2025) · Iranian Biomedical Journal · doi:10.61882/ibj.4212 · Cited by 1
Ikeuchi, K., Tsutsumi, T., Ishizaka, A., Mizutani, T., Sedohara, A., Koga, M., Tamaoki, S., & Yotsuyanagi, H. (2023) · Figshare · doi:10.6084/m9.figshare.22620113
Li, F., Ye, J., Shao, C., & Zhong, B. (2021) · Figshare · doi:10.6084/m9.figshare.14129363
Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights
Ghosh, S., Ghosh, A. J., Adhikari, M. D., Tiwary, B. K., & Saha, T. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01861-3
Llontop, M. E. M., Nauta, K. M., Gates, D. R., Wang, X., Cooper, J. F., & Burton, N. O. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.04.709558
Effect of nonalcoholic fatty liver disease on post-myocardial infarction cardiac remodeling
Biquard, L. (2022) · theses.fr (ABES) · doi:10.70675/4f4848d2z6a02z4576z9fc3zff58e2f5c501
Frăsinariu, O. E., Ștreangă, V., Rugina, A. L., Mîndru, D. E., Vintilă, T. C., Bădulescu, O. V., Bararu‐Bojan, I., Lupu, V. V., Ignat, A., Mihai, A., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19071113
Liu, J., Zhao, M., Wang, S., Zhang, C., Zhong, Y., & Qu, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1917467
Akanbi, A., Bridle, K. R., & Crawford, D. H. (2026) · Bioscience Reports · doi:10.1042/bsr20250106
Yang, X., Chen, J., Song, J., Liu, H., Wang, L., Li, T., Yan, H., Gao, X., & Ding, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1917815
Qin, W., Wang, G., Fu, Y., Zeng, Y., Xia, Y., Sheng, Y., & Ai, L. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11236-y
Gut microbiota shaping fatty liver disease progression
Wysokińska, M., Mysza, M., Uryga, A., & Kolodziejczyk, A. A. (2026) · Life Science Alliance · doi:10.26508/lsa.202603756
Metadata
- Authors
- Da Silva, H. E., Teterina, A., Comelli, E. M., Taibi, A., Arendt, B. M., Fischer, S. E., Lou, W., & Allard, J. P.
- Affiliations
- University Health Network (CA)
- University of Toronto (CA)
- Corresponding author
- Allard, Johane P.
- ORCID
- Venue
- Scientific Reports
- Published
- 2018-01-23
- Volume
- 8
- Issue
- 1
- Pages
- 1466-1466
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5780381
- OpenAlex
- W2803148575
- Cited by
- 283
- References
- 59
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 31 · 2023: 34 · 2022: 35 · 2021: 60 · 2020: 34 · 2019: 27 · 2018: 10
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American College of Gastroenterology
- University of Alberta
- University of Toronto
- Canadian Institutes of Health Research (86922_1, 89705_1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut microbiota, dysbiosis, obesity, insulin resistance, Bacteroidetes, Firmicutes, Faecalibacterium prausnitzii, Ruminococcus, Coprococcus, Lactobacillus, short-chain fatty acids, propionate, isobutyric acid, 2-hydroxybutyrate, L-lactic acid, gut microbiota metabolites
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Cross-Sectional Studies, Feces, Female, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Prospective Studies, Body Mass Index, Young Adult, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
